11 results on '"Ghose, Aniruddha"'
Search Results
2. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS):study protocol for an international randomized clinical trial
- Author
-
Sinnige, Jante S., Smit, Marry R., Ghose, Aniruddha, de Grooth, Harm-Jan, Itenov, Theis Skovsgaard, Ischaki, Eleni, Laffey, John, Paulus, Frederique, Póvoa, Pedro, Pierrakos, Charalampos, Pisani, Luigi, Roca, Oriol, Schultz, Marcus J., Szuldrzynski, Konstanty, Tuinman, Pieter R., Zimatore, Claudio, Bos, Lieuwe D. J., Sinnige, Jante S., Smit, Marry R., Ghose, Aniruddha, de Grooth, Harm-Jan, Itenov, Theis Skovsgaard, Ischaki, Eleni, Laffey, John, Paulus, Frederique, Póvoa, Pedro, Pierrakos, Charalampos, Pisani, Luigi, Roca, Oriol, Schultz, Marcus J., Szuldrzynski, Konstanty, Tuinman, Pieter R., Zimatore, Claudio, and Bos, Lieuwe D. J.
- Abstract
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%. Identifying ARDS subphenotypes based on "focal" or "non-focal" lung morphology has the potential to better target mechanical ventilation strategies of individual patients. However, classifying morphology through chest radiography or computed tomography is either inaccurate or impractical. Lung ultrasound (LUS) is a non-invasive bedside tool that can accurately distinguish "focal" from "non-focal" lung morphology. We hypothesize that LUS-guided personalized mechanical ventilation in ARDS patients leads to a reduction in 90-day mortality compared to conventional mechanical ventilation.METHODS: The Personalized Mechanical Ventilation Guided by UltraSound in Patients with Acute Respiratory Distress Syndrome (PEGASUS) study is an investigator-initiated, international, randomized clinical trial (RCT) that plans to enroll 538 invasively ventilated adult intensive care unit (ICU) patients with moderate to severe ARDS. Eligible patients will receive a LUS exam to classify lung morphology as "focal" or "non-focal". Thereafter, patients will be randomized within 12 h after ARDS diagnosis to receive standard care or personalized ventilation where the ventilation strategy is adjusted to the morphology subphenotype, i.e., higher positive end-expiratory pressure (PEEP) and recruitment maneuvers for "non-focal" ARDS and lower PEEP and prone positioning for "focal" ARDS. The primary endpoint is all-cause mortality at day 90. Secondary outcomes are mortality at day 28, ventilator-free days at day 28, ICU length of stay, ICU mortality, hospital length of stay, hospital mortality, and number of complications (ventilator-associated pneumonia, pneumothorax, and need for rescue therapy). After a pilot phase of 80 patients, the correct interpretation of LUS images and correct application of the intervention within the safe limits
- Published
- 2024
3. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial
- Author
-
Sinnige, Jante J.S., Smit, Marry M.R., Ghose, Aniruddha, de Grooth, Harm Jan, Itenov, Theis Skovsgaard, Ischaki, Eleni, Laffey, John, Paulus, Frederique, Povoa, Pedro, Pierrakos, Charalampos, Pisani, Luigi, Roca, Oriol, Schultz, Marcus M.J., Szuldrzynski, Konstanty, Tuinman, Pieter Roel, Zimatore, Claudio, Bos, Lieuwe D J L.D., Sinnige, Jante J.S., Smit, Marry M.R., Ghose, Aniruddha, de Grooth, Harm Jan, Itenov, Theis Skovsgaard, Ischaki, Eleni, Laffey, John, Paulus, Frederique, Povoa, Pedro, Pierrakos, Charalampos, Pisani, Luigi, Roca, Oriol, Schultz, Marcus M.J., Szuldrzynski, Konstanty, Tuinman, Pieter Roel, Zimatore, Claudio, and Bos, Lieuwe D J L.D.
- Abstract
Background :Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%. Identifying ARDS subphenotypes based on “focal” or “non-focal” lung morphology has the potential to better target mechanical ventilation strategies of individual patients. However, classifying morphology through chest radiography or computed tomography is either inaccurate or impractical. Lung ultrasound (LUS) is a non-invasive bedside tool that can accurately distinguish “focal” from “non-focal” lung morphology. We hypothesize that LUS-guided personalized mechanical ventilation in ARDS patients leads to a reduction in 90-day mortality compared to conventional mechanical ventilation. Methods: The Personalized Mechanical Ventilation Guided by UltraSound in Patients with Acute Respiratory Distress Syndrome (PEGASUS) study is an investigator-initiated, international, randomized clinical trial (RCT) that plans to enroll 538 invasively ventilated adult intensive care unit (ICU) patients with moderate to severe ARDS. Eligible patients will receive a LUS exam to classify lung morphology as “focal” or “non-focal”. Thereafter, patients will be randomized within 12 h after ARDS diagnosis to receive standard care or personalized ventilation where the ventilation strategy is adjusted to the morphology subphenotype, i.e. higher positive end-expiratory pressure (PEEP) and recruitment maneuvers for “non-focal” ARDS and lower PEEP and prone positioning for “focal” ARDS. The primary endpoint is all-cause mortality at day 90. Secondary outcomes are mortality at day 28, ventilator-free days at day 28, ICU length of stay, ICU mortality, hospital length of stay, hospital mortality, and number of complications (ventilator-associated pneumonia, pneumothorax, and need for rescue therapy). After a pilot phase of 80 patients, the correct interpretation of LUS images and correct application of the intervention within the safe limits of mechani, SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2024
4. Personalized Mechanical Ventilation Guided by UltraSound in Patients with Acute Respiratory Distress Syndrome (PEGASUS): study protocol for an international randomized clinical trial.
- Author
-
Sinnige, Jante, primary, Smit, Marry, additional, Ghose, Aniruddha, additional, de Grooth, Harm-Jan, additional, Itenov, Theis Skovsgaard, additional, Ischaki, Eleni, additional, Laffey, John, additional, Paulus, Frederique, additional, Póvoa, Pedro, additional, Pierrakos, Charalampos, additional, Pisani, Luigi, additional, Roca, Oriol, additional, Schultz, Marcus, additional, Szuldrzynski, Konstanty, additional, Tuinman, Pieter Roel, additional, Zimatore, Claudio, additional, and Bos, Lieuwe, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Mystery Under the Hood: Ability of Spitting Among the Morphologically Indistinct Population of Naja Kaouthia (Squamata: Elapidae)
- Author
-
Rahman, Md. Mizanur, primary, Noman, Mohammed, additional, Uddin, Md. Asir, additional, Al Haidar, Ibrahim Khalil, additional, Shaikh, Abdul Auawal, additional, Islam, Md. Rafiqul, additional, Rudra, Sajib, additional, Abu Sayeed, Abdullah, additional, Amin, Mohammad Robed, additional, Kuch, Ulrich, additional, Ghose, Aniruddha, additional, Ahsan, Md. Farid, additional, Faiz, Md. Abul, additional, and Chowdhury, Mohammad Abdul Wahed, additional
- Published
- 2024
- Full Text
- View/download PDF
6. Combining species distribution models and big datasets may provide finer assessments of snakebite impacts.
- Author
-
Chowdhury, Mohammad Abdul Wahed, Müller, Johannes, Ghose, Aniruddha, Amin, Robed, Sayeed, Abdullah Abu, Kuch, Ulrich, and Faiz, Mohammad Abul
- Subjects
SNAKEBITES ,SPECIES distribution ,MEDICAL climatology ,POPULATION density ,NEGLECTED diseases ,CLIMATE change - Abstract
Background: Snakebite is a major poverty-related neglected tropical disease. An integrated scientific approach is needed to understand the dynamics of this important health issue. Our objective was to estimate snakebite occurrence in a tropical area by using a blend of ecological modelling and robust statistical analysis. Methods: The present study used climatic, environmental, and human population density data to determine the area with snakebite occurrence-probability for the first time in Bangladesh. We also analysed a large, 16-year dataset of hospitalized snakebite cases to reveal the epidemiology of snakebite in the south-eastern zone of the country. Findings: Our results show that cobra bite is the most commonly occurring venomous snakebite in humans (around ~12% of the total yearly snakebite records), and men are more frequently bitten than women (2/3 of human victims are men). Most bites occur during the rainy season for cobra and green pit viper, while krait bites are not restricted to any particular season. As snakebite incidents are closely related to climate conditions, we can model snakebite risk using temperature and precipitation variables. Whereas there is a lack of snakebite reports from several parts of the study area in official records, our models predict that the entire study area is favourable for snakebite incidents. Based on the combined evidence we estimate that about 200,000 snakebite events occur every year in the south-eastern part of Bangladesh alone. Considering future global climate change, our model projections show that snakebite incidence in Bangladesh might not significantly decrease in the future (- 2070-); however, the distribution of probabilities might change, with a predicted increase of snakebite incidence in the hilly areas of the country. Conclusions: Using climatic data to predict snakebite incidence in Bangladesh allowed us to provide estimations of the total annual number of snakebite cases in the study area. As in most countries, the scarcity of accurate epidemiological data in official records might have masked the real magnitude of this problem. Our analysis suggests that the problem of snakebite envenoming in Bangladesh might be worse than currently perceived. A long-term sustainable snakebite program plan should be designed and institutionalized, considering climatic, geographical and human demographic variables, to obtain better data and facilitate the implementation of accurate snakebite management programs for this country. Author summary: Snakebite envenoming is an important health problem in Bangladesh. A community-based survey conducted in 2009 indicated that around 700,000 snakebites/year may occur in this country. However, until now, there is no study estimating the incidence of snakebite in Bangladesh from the aspect of ecology. Considering the climatic, environmental, and human population variables, a large, 16-year clinico-epidemiological dataset of snakebite patients was analysed to portray snakebite occurrence probability in Chattogram Division, which comprises the south-eastern part of Bangladesh. Five species distribution models were used to map snakebite-prone areas. We found that the study area has large differences in the predicted incidence of snakebite. Our predictions indicate that around 200,000 snakebite cases per year might occur in the study area, where the latest estimate on 2009 estimated less than half that number for this division. Further, predictions for the year 2070 provide us with similar numbers, independent of the global increase in temperature. As snakebite will remain a major health problem for this country in the next 50 years, we propose the development of a sustainable management plan aiming to limit human-snake conflicts and their consequences while safeguarding also snakes and the ecosystem services they provide especially to agriculture. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Lessons from the field: compound-specific management in acute pesticide poisoning.
- Author
-
Verma, Vasundhara R, Lamb, Thomas, Sattar, Md Abdus, Ghose, Aniruddha, and Eddleston, Michael
- Subjects
POISONING ,PESTICIDES ,MEDICAL emergencies ,LENGTH of stay in hospitals ,HOSPITAL costs ,ABORTIFACIENTS - Abstract
Pesticide poisoning is a common medical emergency in the rural tropics, with significant associated mortality. Pesticide poisoning is an umbrella term that encompasses a wide variety of substances with differing clinical toxidromes and outcomes. Despite this, confirmation of the specific compound ingested is rarely performed. In this Lessons from the Field, we argue that pesticide-specific management is integral to optimise management. Using data from a quality improvement project in Chittagong, Bangladesh, we demonstrate that identifying the specific compound is possible in most patients through careful history taking and examination of the pesticide bottle. Identification of the specific compound is essential for anticipating and reducing complications, administering appropriate and timely management and reducing the length of hospital stay and cost of unnecessary medical intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Non-COVID-19 intensive care admissions during the pandemic: a multinational registry-based study
- Author
-
McLarty, Joshua, Litton, Edward, Beane, Abigail, Aryal, Diptesh, Bailey, Michael, Bendel, Stepani, Burghi, Gaston, Christensen, Steffen, Christiansen, Christian Fynbo, Dongelmans, Dave A, Fernandez, Ariel L, Ghose, Aniruddha, Hall, Ros, Haniffa, Rashan, Hashmi, Madiha, Hashimoto, Satoru, Ichihara, Nao, Kumar Tirupakuzhi Vijayaraghavan, Bharath, Lone, Nazir I, Arias López, Maria del Pilar, Mat Nor, Mohamed Basri, Okamoto, Hiroshi, Priyadarshani, Dilanthi, Reinikainen, Matti, Soares, Marcio, Pilcher, David, and Salluh, Jorge
- Abstract
BackgroundThe COVID-19 pandemic resulted in a large number of critical care admissions. While national reports have described the outcomes of patients with COVID-19, there is limited international data of the pandemic impact on non-COVID-19 patients requiring intensive care treatment.MethodsWe conducted an international, retrospective cohort study using 2019 and 2020 data from 11 national clinical quality registries covering 15 countries. Non-COVID-19 admissions in 2020 were compared with all admissions in 2019, prepandemic. The primary outcome was intensive care unit (ICU) mortality. Secondary outcomes included in-hospital mortality and standardised mortality ratio (SMR). Analyses were stratified by the country income level(s) of each registry.FindingsAmong 1 642 632 non-COVID-19 admissions, there was an increase in ICU mortality between 2019 (9.3%) and 2020 (10.4%), OR=1.15 (95% CI 1.14 to 1.17, p<0.001). Increased mortality was observed in middle-income countries (OR 1.25 95% CI 1.23 to 1.26), while mortality decreased in high-income countries (OR=0.96 95% CI 0.94 to 0.98). Hospital mortality and SMR trends for each registry were consistent with the observed ICU mortality findings. The burden of COVID-19 was highly variable, with COVID-19 ICU patient-days per bed ranging from 0.4 to 81.6 between registries. This alone did not explain the observed non-COVID-19 mortality changes.InterpretationIncreased ICU mortality occurred among non-COVID-19 patients during the pandemic, driven by increased mortality in middle-income countries, while mortality decreased in high-income countries. The causes for this inequity are likely multi-factorial, but healthcare spending, policy pandemic responses, and ICU strain may play significant roles.
- Published
- 2024
- Full Text
- View/download PDF
9. Snakebite epidemiology – findings from a nationally conducted survey in Bangladesh.
- Author
-
Ghose, Aniruddha, Chowdhury, Salim Mahmud, Sayeed, Abdullah Abu, Hossain, Jahangir, Md Erfan Uddin, Rabiul Alam, Md Mahabubur Rahman, Abu Shahin, Ahmed, Helal Uddin, Acharjee, Panchanan, Rashid, Rumana, Chowdhury, Sharmin, Chowdhury, Abdul Wahed, Kuch, Ulrich, Rahman, Ridwanur, Amin, Md Robed, Rahman, AKM Fazlur, and Faiz, M.A.
- Subjects
- *
EPIDEMIOLOGY - Published
- 2024
- Full Text
- View/download PDF
10. Understanding patient and family experiences of critical care in Bangladesh and India: What are the priority actions to promote person-centred care?
- Author
-
Inglis R, Leaver M, Pell C, Ahmad S, Akter S, Bhuia FIA, Ansary M, B S S, Begum M, Chakraborty SR, Chowdhury H, Chowdhury MAR, Deb P, Akhter Farzana N, Ghose A, Harun Or Roshid M, Hoque Tipu MR, Hosain S, Hossain MM, Moinul Islam M, Kumar Tirupakuzhi Vijayaraghavan B, Mohsin M, Mund M, Nasrin S, Kumar Nath R, Nayak S, Pani N, Ahmmad Sarker S, Dondorp A, Tripathy S, and Faiz MA
- Abstract
Patients' experiences in the intensive care unit (ICU) can enhance or impair their subsequent recovery. Improving patient and family experiences on the ICU is an important part of providing high quality care. There is little evidence to guide how to do this in a South Asian critical care context. This study addresses this gap by exploring the experiences of critically ill patients and their families in ICUs in Bangladesh and India. We elicit suggestions for improvements from patients, families and staff and highlight examples of practices that support person-centred care. This multi-site hospital ethnography was carried out in five ICUs in government hospitals in Bangladesh and India, selected using purposive sampling. Qualitative data were collected using non-participant observation and semi-structured interviews and analysed using reflexive thematic analysis. A total of 108 interviews were conducted with patients, families, and ICU staff. Over 1000 hours of observation were carried out across the five study sites. We identified important mediators of patient and family experience that span many different aspects of care. Factors that promote person-centred care include access to ICU for families, support for family involvement in care delivery, clear communication with patients and families, good symptom management for patients, support for rehabilitation, and measures to address the physical, environmental and financial needs of the family. This study has generated a list of recommendations that can be used by policy makers and practitioners who wish to implement person-centred principles in the ICU., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Inglis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
11. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial.
- Author
-
Sinnige JS, Smit MR, Ghose A, de Grooth HJ, Itenov TS, Ischaki E, Laffey J, Paulus F, Póvoa P, Pierrakos C, Pisani L, Roca O, Schultz MJ, Szuldrzynski K, Tuinman PR, Zimatore C, and Bos LDJ
- Subjects
- Humans, Treatment Outcome, Time Factors, Multicenter Studies as Topic, Predictive Value of Tests, Precision Medicine methods, Respiratory Distress Syndrome therapy, Respiratory Distress Syndrome diagnostic imaging, Respiratory Distress Syndrome mortality, Respiration, Artificial methods, Randomized Controlled Trials as Topic, Lung diagnostic imaging, Lung physiopathology, Ultrasonography, Interventional methods
- Abstract
Background: Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%. Identifying ARDS subphenotypes based on "focal" or "non-focal" lung morphology has the potential to better target mechanical ventilation strategies of individual patients. However, classifying morphology through chest radiography or computed tomography is either inaccurate or impractical. Lung ultrasound (LUS) is a non-invasive bedside tool that can accurately distinguish "focal" from "non-focal" lung morphology. We hypothesize that LUS-guided personalized mechanical ventilation in ARDS patients leads to a reduction in 90-day mortality compared to conventional mechanical ventilation., Methods: The Personalized Mechanical Ventilation Guided by UltraSound in Patients with Acute Respiratory Distress Syndrome (PEGASUS) study is an investigator-initiated, international, randomized clinical trial (RCT) that plans to enroll 538 invasively ventilated adult intensive care unit (ICU) patients with moderate to severe ARDS. Eligible patients will receive a LUS exam to classify lung morphology as "focal" or "non-focal". Thereafter, patients will be randomized within 12 h after ARDS diagnosis to receive standard care or personalized ventilation where the ventilation strategy is adjusted to the morphology subphenotype, i.e., higher positive end-expiratory pressure (PEEP) and recruitment maneuvers for "non-focal" ARDS and lower PEEP and prone positioning for "focal" ARDS. The primary endpoint is all-cause mortality at day 90. Secondary outcomes are mortality at day 28, ventilator-free days at day 28, ICU length of stay, ICU mortality, hospital length of stay, hospital mortality, and number of complications (ventilator-associated pneumonia, pneumothorax, and need for rescue therapy). After a pilot phase of 80 patients, the correct interpretation of LUS images and correct application of the intervention within the safe limits of mechanical ventilation will be evaluated., Discussion: PEGASUS is the first RCT that compares LUS-guided personalized mechanical ventilation with conventional ventilation in invasively ventilated patients with moderate and severe ARDS. If this study demonstrates that personalized ventilation guided by LUS can improve the outcomes of ARDS patients, it has the potential to shift the existing one-size-fits-all ventilation strategy towards a more individualized approach., Trial Registration: The PEGASUS trial was registered before the inclusion of the first patient, https://clinicaltrials.gov/ (ID: NCT05492344)., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.